Literature DB >> 17470654

Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.

Minyi Shi1, Xin Wang, Erik De Clercq, Sonshin Takao, Masanori Baba.   

Abstract

Several anti-human immunodeficiency virus type 1 reverse transcriptase inhibitors were evaluated for their antiviral activities against porcine endogenous retrovirus in human cells. Among the test compounds, zidovudine was found to be the most active. The order of potency was zidovudine > phosphonylmethoxyethoxydiaminopyrimidine = phosphonylmethoxypropyldiaminopurine > tenofovir > or = adefovir > stavudine.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17470654      PMCID： PMC1913248          DOI： 10.1128/AAC.00212-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses.

Authors:  S K Powell; M E Gates; G Langford; M L Gu; C Lockey; Z Long; E Otto
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

Authors:  Erik De Clercq
Journal:  Antiviral Res       Date:  2006-11-07       Impact factor: 5.970

3.  Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

Authors:  K Paradis; G Langford; Z Long; W Heneine; P Sandstrom; W M Switzer; L E Chapman; C Lockey; D Onions; E Otto
Journal:  Science       Date:  1999-08-20       Impact factor: 47.728

4.  Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.

Authors:  C Ying; A Holy; D Hocková; Z Havlas; E De Clercq; J Neyts
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.

Authors:  Takao Nitanda; Xin Wang; Hiroki Kumamoto; Kazuhiro Haraguchi; Hiromichi Tanaka; Yung-Chi Cheng; Masanori Baba
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors.

Authors:  S H Qari; S Magre; J G García-Lerma; A I Hussain; Y Takeuchi; C Patience; R A Weiss; W Heneine
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  The potential role of xenotransplantation in treating endstage cardiac disease: a summary of the report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation.

Authors:  D K Cooper; A M Keogh
Journal:  Curr Opin Cardiol       Date:  2001-03       Impact factor: 2.161

Review 8.  Acyclic nucleoside phosphonates: a key class of antiviral drugs.

Authors:  Erik De Clercq; Antonín Holý
Journal:  Nat Rev Drug Discov       Date:  2005-11       Impact factor: 84.694

9.  No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys.

Authors:  C Patience; G S Patton; Y Takeuchi; R A Weiss; M O McClure; L Rydberg; M E Breimer
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

10.  Packaging of human endogenous retrovirus sequences is undetectable in porcine endogenous retrovirus particles produced from human cells.

Authors:  Kristen Suling; Gary Quinn; James Wood; Clive Patience
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616
View more
  3 in total

1.  Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.

Authors:  Takele Argaw; Winston Colon-Moran; Carolyn Wilson
Journal:  Xenotransplantation       Date:  2016-03-29       Impact factor: 3.907

2.  Infection in xenotransplantation: opportunities and challenges.

Authors:  Jay A Fishman
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

Review 3.  Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?

Authors:  Joachim Denner
Journal:  Viruses       Date:  2017-08-08       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.